Table of Content

1 Sustained Release Ocular Drug Delivery Systems Market Overview
1.1 Product Overview and Scope of Sustained Release Ocular Drug Delivery Systems
1.2 Sustained Release Ocular Drug Delivery Systems Segment by Type
1.2.1 Global Sustained Release Ocular Drug Delivery Systems Market Value Comparison by Type (2024-2034)
1.2.2 Liposome
1.2.3 Microcapsules/Nanocapsules
1.2.4 Microspheres/Nanosptheres
1.2.5 Implants
1.3 Sustained Release Ocular Drug Delivery Systems Segment by Application
1.3.1 Global Sustained Release Ocular Drug Delivery Systems Market Value by Application: (2024-2034)
1.3.2 Cataract
1.3.3 Glaucoma
1.3.4 Corneal Transplantation
1.3.5 Others
1.4 Global Sustained Release Ocular Drug Delivery Systems Market Size Estimates and Forecasts
1.4.1 Global Sustained Release Ocular Drug Delivery Systems Revenue 2018-2034
1.4.2 Global Sustained Release Ocular Drug Delivery Systems Sales 2018-2034
1.4.3 Global Sustained Release Ocular Drug Delivery Systems Market Average Price (2018-2034)
1.5 Assumptions and Limitations
2 Sustained Release Ocular Drug Delivery Systems Market Competition by Manufacturers
2.1 Global Sustained Release Ocular Drug Delivery Systems Sales Market Share by Manufacturers (2018-2024)
2.2 Global Sustained Release Ocular Drug Delivery Systems Revenue Market Share by Manufacturers (2018-2024)
2.3 Global Sustained Release Ocular Drug Delivery Systems Average Price by Manufacturers (2018-2024)
2.4 Global Sustained Release Ocular Drug Delivery Systems Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Sustained Release Ocular Drug Delivery Systems, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Sustained Release Ocular Drug Delivery Systems, Product Type & Application
2.7 Sustained Release Ocular Drug Delivery Systems Market Competitive Situation and Trends
2.7.1 Sustained Release Ocular Drug Delivery Systems Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Sustained Release Ocular Drug Delivery Systems Players Market Share by Revenue
2.7.3 Global Sustained Release Ocular Drug Delivery Systems Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Sustained Release Ocular Drug Delivery Systems Retrospective Market Scenario by Region
3.1 Global Sustained Release Ocular Drug Delivery Systems Market Size by Region: 2018 Versus 2022 Versus 2034
3.2 Global Sustained Release Ocular Drug Delivery Systems Global Sustained Release Ocular Drug Delivery Systems Sales by Region: 2018-2034
3.2.1 Global Sustained Release Ocular Drug Delivery Systems Sales by Region: 2018-2024
3.2.2 Global Sustained Release Ocular Drug Delivery Systems Sales by Region: 2024-2034
3.3 Global Sustained Release Ocular Drug Delivery Systems Global Sustained Release Ocular Drug Delivery Systems Revenue by Region: 2018-2034
3.3.1 Global Sustained Release Ocular Drug Delivery Systems Revenue by Region: 2018-2024
3.3.2 Global Sustained Release Ocular Drug Delivery Systems Revenue by Region: 2024-2034
3.4 North America Sustained Release Ocular Drug Delivery Systems Market Facts & Figures by Country
3.4.1 North America Sustained Release Ocular Drug Delivery Systems Market Size by Country: 2018 VS 2022 VS 2034
3.4.2 North America Sustained Release Ocular Drug Delivery Systems Sales by Country (2018-2034)
3.4.3 North America Sustained Release Ocular Drug Delivery Systems Revenue by Country (2018-2034)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Sustained Release Ocular Drug Delivery Systems Market Facts & Figures by Country
3.5.1 Europe Sustained Release Ocular Drug Delivery Systems Market Size by Country: 2018 VS 2022 VS 2034
3.5.2 Europe Sustained Release Ocular Drug Delivery Systems Sales by Country (2018-2034)
3.5.3 Europe Sustained Release Ocular Drug Delivery Systems Revenue by Country (2018-2034)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Sustained Release Ocular Drug Delivery Systems Market Facts & Figures by Country
3.6.1 Asia Pacific Sustained Release Ocular Drug Delivery Systems Market Size by Country: 2018 VS 2022 VS 2034
3.6.2 Asia Pacific Sustained Release Ocular Drug Delivery Systems Sales by Country (2018-2034)
3.6.3 Asia Pacific Sustained Release Ocular Drug Delivery Systems Revenue by Country (2018-2034)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Sustained Release Ocular Drug Delivery Systems Market Facts & Figures by Country
3.7.1 Latin America Sustained Release Ocular Drug Delivery Systems Market Size by Country: 2018 VS 2022 VS 2034
3.7.2 Latin America Sustained Release Ocular Drug Delivery Systems Sales by Country (2018-2034)
3.7.3 Latin America Sustained Release Ocular Drug Delivery Systems Revenue by Country (2018-2034)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Sustained Release Ocular Drug Delivery Systems Market Facts & Figures by Country
3.8.1 Middle East and Africa Sustained Release Ocular Drug Delivery Systems Market Size by Country: 2018 VS 2022 VS 2034
3.8.2 Middle East and Africa Sustained Release Ocular Drug Delivery Systems Sales by Country (2018-2034)
3.8.3 Middle East and Africa Sustained Release Ocular Drug Delivery Systems Revenue by Country (2018-2034)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Sustained Release Ocular Drug Delivery Systems Sales by Type (2018-2034)
4.1.1 Global Sustained Release Ocular Drug Delivery Systems Sales by Type (2018-2024)
4.1.2 Global Sustained Release Ocular Drug Delivery Systems Sales by Type (2024-2034)
4.1.3 Global Sustained Release Ocular Drug Delivery Systems Sales Market Share by Type (2018-2034)
4.2 Global Sustained Release Ocular Drug Delivery Systems Revenue by Type (2018-2034)
4.2.1 Global Sustained Release Ocular Drug Delivery Systems Revenue by Type (2018-2024)
4.2.2 Global Sustained Release Ocular Drug Delivery Systems Revenue by Type (2024-2034)
4.2.3 Global Sustained Release Ocular Drug Delivery Systems Revenue Market Share by Type (2018-2034)
4.3 Global Sustained Release Ocular Drug Delivery Systems Price by Type (2018-2034)
5 Segment by Application
5.1 Global Sustained Release Ocular Drug Delivery Systems Sales by Application (2018-2034)
5.1.1 Global Sustained Release Ocular Drug Delivery Systems Sales by Application (2018-2024)
5.1.2 Global Sustained Release Ocular Drug Delivery Systems Sales by Application (2024-2034)
5.1.3 Global Sustained Release Ocular Drug Delivery Systems Sales Market Share by Application (2018-2034)
5.2 Global Sustained Release Ocular Drug Delivery Systems Revenue by Application (2018-2034)
5.2.1 Global Sustained Release Ocular Drug Delivery Systems Revenue by Application (2018-2024)
5.2.2 Global Sustained Release Ocular Drug Delivery Systems Revenue by Application (2024-2034)
5.2.3 Global Sustained Release Ocular Drug Delivery Systems Revenue Market Share by Application (2018-2034)
5.3 Global Sustained Release Ocular Drug Delivery Systems Price by Application (2018-2034)
6 Key Companies Profiled
6.1 pSivida
6.1.1 pSivida Corporation Information
6.1.2 pSivida Description and Business Overview
6.1.3 pSivida Sustained Release Ocular Drug Delivery Systems Sales, Revenue and Gross Margin (2018-2024)
6.1.4 pSivida Sustained Release Ocular Drug Delivery Systems Product Portfolio
6.1.5 pSivida Recent Developments/Updates
6.2 Allergan
6.2.1 Allergan Corporation Information
6.2.2 Allergan Description and Business Overview
6.2.3 Allergan Sustained Release Ocular Drug Delivery Systems Sales, Revenue and Gross Margin (2018-2024)
6.2.4 Allergan Sustained Release Ocular Drug Delivery Systems Product Portfolio
6.2.5 Allergan Recent Developments/Updates
6.3 Icon Bioscience
6.3.1 Icon Bioscience Corporation Information
6.3.2 Icon Bioscience Description and Business Overview
6.3.3 Icon Bioscience Sustained Release Ocular Drug Delivery Systems Sales, Revenue and Gross Margin (2018-2024)
6.3.4 Icon Bioscience Sustained Release Ocular Drug Delivery Systems Product Portfolio
6.3.5 Icon Bioscience Recent Developments/Updates
6.4 Ocular Therapeutix
6.4.1 Ocular Therapeutix Corporation Information
6.4.2 Ocular Therapeutix Description and Business Overview
6.4.3 Ocular Therapeutix Sustained Release Ocular Drug Delivery Systems Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Ocular Therapeutix Sustained Release Ocular Drug Delivery Systems Product Portfolio
6.4.5 Ocular Therapeutix Recent Developments/Updates
6.5 Neurotech Pharmaceuticals
6.5.1 Neurotech Pharmaceuticals Corporation Information
6.5.2 Neurotech Pharmaceuticals Description and Business Overview
6.5.3 Neurotech Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Sales, Revenue and Gross Margin (2018-2024)
6.5.4 Neurotech Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Product Portfolio
6.5.5 Neurotech Pharmaceuticals Recent Developments/Updates
6.6 Santen Pharmaceutical
6.6.1 Santen Pharmaceutical Corporation Information
6.6.2 Santen Pharmaceutical Description and Business Overview
6.6.3 Santen Pharmaceutical Sustained Release Ocular Drug Delivery Systems Sales, Revenue and Gross Margin (2018-2024)
6.6.4 Santen Pharmaceutical Sustained Release Ocular Drug Delivery Systems Product Portfolio
6.6.5 Santen Pharmaceutical Recent Developments/Updates
6.7 Aciont Inc.
6.6.1 Aciont Inc. Corporation Information
6.6.2 Aciont Inc. Description and Business Overview
6.6.3 Aciont Inc. Sustained Release Ocular Drug Delivery Systems Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Aciont Inc. Sustained Release Ocular Drug Delivery Systems Product Portfolio
6.7.5 Aciont Inc. Recent Developments/Updates
6.8 Envisia Therapeutics
6.8.1 Envisia Therapeutics Corporation Information
6.8.2 Envisia Therapeutics Description and Business Overview
6.8.3 Envisia Therapeutics Sustained Release Ocular Drug Delivery Systems Sales, Revenue and Gross Margin (2018-2024)
6.8.4 Envisia Therapeutics Sustained Release Ocular Drug Delivery Systems Product Portfolio
6.8.5 Envisia Therapeutics Recent Developments/Updates
6.9 GrayBug
6.9.1 GrayBug Corporation Information
6.9.2 GrayBug Description and Business Overview
6.9.3 GrayBug Sustained Release Ocular Drug Delivery Systems Sales, Revenue and Gross Margin (2018-2024)
6.9.4 GrayBug Sustained Release Ocular Drug Delivery Systems Product Portfolio
6.9.5 GrayBug Recent Developments/Updates
6.10 Innocore Pharmaceuticals
6.10.1 Innocore Pharmaceuticals Corporation Information
6.10.2 Innocore Pharmaceuticals Description and Business Overview
6.10.3 Innocore Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Sales, Revenue and Gross Margin (2018-2024)
6.10.4 Innocore Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Product Portfolio
6.10.5 Innocore Pharmaceuticals Recent Developments/Updates
6.11 OHR Pharmaceuticals
6.11.1 OHR Pharmaceuticals Corporation Information
6.11.2 OHR Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Description and Business Overview
6.11.3 OHR Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Sales, Revenue and Gross Margin (2018-2024)
6.11.4 OHR Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Product Portfolio
6.11.5 OHR Pharmaceuticals Recent Developments/Updates
6.12 PolyActiva
6.12.1 PolyActiva Corporation Information
6.12.2 PolyActiva Sustained Release Ocular Drug Delivery Systems Description and Business Overview
6.12.3 PolyActiva Sustained Release Ocular Drug Delivery Systems Sales, Revenue and Gross Margin (2018-2024)
6.12.4 PolyActiva Sustained Release Ocular Drug Delivery Systems Product Portfolio
6.12.5 PolyActiva Recent Developments/Updates
6.13 TheraKine
6.13.1 TheraKine Corporation Information
6.13.2 TheraKine Sustained Release Ocular Drug Delivery Systems Description and Business Overview
6.13.3 TheraKine Sustained Release Ocular Drug Delivery Systems Sales, Revenue and Gross Margin (2018-2024)
6.13.4 TheraKine Sustained Release Ocular Drug Delivery Systems Product Portfolio
6.13.5 TheraKine Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Sustained Release Ocular Drug Delivery Systems Industry Chain Analysis
7.2 Sustained Release Ocular Drug Delivery Systems Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Sustained Release Ocular Drug Delivery Systems Production Mode & Process
7.4 Sustained Release Ocular Drug Delivery Systems Sales and Marketing
7.4.1 Sustained Release Ocular Drug Delivery Systems Sales Channels
7.4.2 Sustained Release Ocular Drug Delivery Systems Distributors
7.5 Sustained Release Ocular Drug Delivery Systems Customers
8 Sustained Release Ocular Drug Delivery Systems Market Dynamics
8.1 Sustained Release Ocular Drug Delivery Systems Industry Trends
8.2 Sustained Release Ocular Drug Delivery Systems Market Drivers
8.3 Sustained Release Ocular Drug Delivery Systems Market Challenges
8.4 Sustained Release Ocular Drug Delivery Systems Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Sustained Release Ocular Drug Delivery Systems Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Sustained Release Ocular Drug Delivery Systems Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Sustained Release Ocular Drug Delivery Systems Market Competitive Situation by Manufacturers in 2022
Table 4. Global Sustained Release Ocular Drug Delivery Systems Sales (K Pcs) of Key Manufacturers (2018-2024)
Table 5. Global Sustained Release Ocular Drug Delivery Systems Sales Market Share by Manufacturers (2018-2024)
Table 6. Global Sustained Release Ocular Drug Delivery Systems Revenue (US$ Million) by Manufacturers (2018-2024)
Table 7. Global Sustained Release Ocular Drug Delivery Systems Revenue Share by Manufacturers (2018-2024)
Table 8. Global Market Sustained Release Ocular Drug Delivery Systems Average Price (USD/Pcs) of Key Manufacturers (2018-2024)
Table 9. Global Key Players of Sustained Release Ocular Drug Delivery Systems, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Sustained Release Ocular Drug Delivery Systems, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Sustained Release Ocular Drug Delivery Systems, Product Type & Application
Table 12. Global Key Manufacturers of Sustained Release Ocular Drug Delivery Systems, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Sustained Release Ocular Drug Delivery Systems by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sustained Release Ocular Drug Delivery Systems as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Sustained Release Ocular Drug Delivery Systems Market Size by Region (US$ Million): 2018 VS 2022 VS 2034
Table 17. Global Sustained Release Ocular Drug Delivery Systems Sales by Region (2018-2024) & (K Pcs)
Table 18. Global Sustained Release Ocular Drug Delivery Systems Sales Market Share by Region (2018-2024)
Table 19. Global Sustained Release Ocular Drug Delivery Systems Sales by Region (2024-2034) & (K Pcs)
Table 20. Global Sustained Release Ocular Drug Delivery Systems Sales Market Share by Region (2024-2034)
Table 21. Global Sustained Release Ocular Drug Delivery Systems Revenue by Region (2018-2024) & (US$ Million)
Table 22. Global Sustained Release Ocular Drug Delivery Systems Revenue Market Share by Region (2018-2024)
Table 23. Global Sustained Release Ocular Drug Delivery Systems Revenue by Region (2024-2034) & (US$ Million)
Table 24. Global Sustained Release Ocular Drug Delivery Systems Revenue Market Share by Region (2024-2034)
Table 25. North America Sustained Release Ocular Drug Delivery Systems Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 26. North America Sustained Release Ocular Drug Delivery Systems Sales by Country (2018-2024) & (K Pcs)
Table 27. North America Sustained Release Ocular Drug Delivery Systems Sales by Country (2024-2034) & (K Pcs)
Table 28. North America Sustained Release Ocular Drug Delivery Systems Revenue by Country (2018-2024) & (US$ Million)
Table 29. North America Sustained Release Ocular Drug Delivery Systems Revenue by Country (2024-2034) & (US$ Million)
Table 30. Europe Sustained Release Ocular Drug Delivery Systems Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 31. Europe Sustained Release Ocular Drug Delivery Systems Sales by Country (2018-2024) & (K Pcs)
Table 32. Europe Sustained Release Ocular Drug Delivery Systems Sales by Country (2024-2034) & (K Pcs)
Table 33. Europe Sustained Release Ocular Drug Delivery Systems Revenue by Country (2018-2024) & (US$ Million)
Table 34. Europe Sustained Release Ocular Drug Delivery Systems Revenue by Country (2024-2034) & (US$ Million)
Table 35. Asia Pacific Sustained Release Ocular Drug Delivery Systems Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 36. Asia Pacific Sustained Release Ocular Drug Delivery Systems Sales by Region (2018-2024) & (K Pcs)
Table 37. Asia Pacific Sustained Release Ocular Drug Delivery Systems Sales by Region (2024-2034) & (K Pcs)
Table 38. Asia Pacific Sustained Release Ocular Drug Delivery Systems Revenue by Region (2018-2024) & (US$ Million)
Table 39. Asia Pacific Sustained Release Ocular Drug Delivery Systems Revenue by Region (2024-2034) & (US$ Million)
Table 40. Latin America Sustained Release Ocular Drug Delivery Systems Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 41. Latin America Sustained Release Ocular Drug Delivery Systems Sales by Country (2018-2024) & (K Pcs)
Table 42. Latin America Sustained Release Ocular Drug Delivery Systems Sales by Country (2024-2034) & (K Pcs)
Table 43. Latin America Sustained Release Ocular Drug Delivery Systems Revenue by Country (2018-2024) & (US$ Million)
Table 44. Latin America Sustained Release Ocular Drug Delivery Systems Revenue by Country (2024-2034) & (US$ Million)
Table 45. Middle East & Africa Sustained Release Ocular Drug Delivery Systems Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 46. Middle East & Africa Sustained Release Ocular Drug Delivery Systems Sales by Country (2018-2024) & (K Pcs)
Table 47. Middle East & Africa Sustained Release Ocular Drug Delivery Systems Sales by Country (2024-2034) & (K Pcs)
Table 48. Middle East & Africa Sustained Release Ocular Drug Delivery Systems Revenue by Country (2018-2024) & (US$ Million)
Table 49. Middle East & Africa Sustained Release Ocular Drug Delivery Systems Revenue by Country (2024-2034) & (US$ Million)
Table 50. Global Sustained Release Ocular Drug Delivery Systems Sales (K Pcs) by Type (2018-2024)
Table 51. Global Sustained Release Ocular Drug Delivery Systems Sales (K Pcs) by Type (2024-2034)
Table 52. Global Sustained Release Ocular Drug Delivery Systems Sales Market Share by Type (2018-2024)
Table 53. Global Sustained Release Ocular Drug Delivery Systems Sales Market Share by Type (2024-2034)
Table 54. Global Sustained Release Ocular Drug Delivery Systems Revenue (US$ Million) by Type (2018-2024)
Table 55. Global Sustained Release Ocular Drug Delivery Systems Revenue (US$ Million) by Type (2024-2034)
Table 56. Global Sustained Release Ocular Drug Delivery Systems Revenue Market Share by Type (2018-2024)
Table 57. Global Sustained Release Ocular Drug Delivery Systems Revenue Market Share by Type (2024-2034)
Table 58. Global Sustained Release Ocular Drug Delivery Systems Price (USD/Pcs) by Type (2018-2024)
Table 59. Global Sustained Release Ocular Drug Delivery Systems Price (USD/Pcs) by Type (2024-2034)
Table 60. Global Sustained Release Ocular Drug Delivery Systems Sales (K Pcs) by Application (2018-2024)
Table 61. Global Sustained Release Ocular Drug Delivery Systems Sales (K Pcs) by Application (2024-2034)
Table 62. Global Sustained Release Ocular Drug Delivery Systems Sales Market Share by Application (2018-2024)
Table 63. Global Sustained Release Ocular Drug Delivery Systems Sales Market Share by Application (2024-2034)
Table 64. Global Sustained Release Ocular Drug Delivery Systems Revenue (US$ Million) by Application (2018-2024)
Table 65. Global Sustained Release Ocular Drug Delivery Systems Revenue (US$ Million) by Application (2024-2034)
Table 66. Global Sustained Release Ocular Drug Delivery Systems Revenue Market Share by Application (2018-2024)
Table 67. Global Sustained Release Ocular Drug Delivery Systems Revenue Market Share by Application (2024-2034)
Table 68. Global Sustained Release Ocular Drug Delivery Systems Price (USD/Pcs) by Application (2018-2024)
Table 69. Global Sustained Release Ocular Drug Delivery Systems Price (USD/Pcs) by Application (2024-2034)
Table 70. pSivida Corporation Information
Table 71. pSivida Description and Business Overview
Table 72. pSivida Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 73. pSivida Sustained Release Ocular Drug Delivery Systems Product
Table 74. pSivida Recent Developments/Updates
Table 75. Allergan Corporation Information
Table 76. Allergan Description and Business Overview
Table 77. Allergan Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 78. Allergan Sustained Release Ocular Drug Delivery Systems Product
Table 79. Allergan Recent Developments/Updates
Table 80. Icon Bioscience Corporation Information
Table 81. Icon Bioscience Description and Business Overview
Table 82. Icon Bioscience Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 83. Icon Bioscience Sustained Release Ocular Drug Delivery Systems Product
Table 84. Icon Bioscience Recent Developments/Updates
Table 85. Ocular Therapeutix Corporation Information
Table 86. Ocular Therapeutix Description and Business Overview
Table 87. Ocular Therapeutix Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 88. Ocular Therapeutix Sustained Release Ocular Drug Delivery Systems Product
Table 89. Ocular Therapeutix Recent Developments/Updates
Table 90. Neurotech Pharmaceuticals Corporation Information
Table 91. Neurotech Pharmaceuticals Description and Business Overview
Table 92. Neurotech Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 93. Neurotech Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Product
Table 94. Neurotech Pharmaceuticals Recent Developments/Updates
Table 95. Santen Pharmaceutical Corporation Information
Table 96. Santen Pharmaceutical Description and Business Overview
Table 97. Santen Pharmaceutical Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 98. Santen Pharmaceutical Sustained Release Ocular Drug Delivery Systems Product
Table 99. Santen Pharmaceutical Recent Developments/Updates
Table 100. Aciont Inc. Corporation Information
Table 101. Aciont Inc. Description and Business Overview
Table 102. Aciont Inc. Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 103. Aciont Inc. Sustained Release Ocular Drug Delivery Systems Product
Table 104. Aciont Inc. Recent Developments/Updates
Table 105. Envisia Therapeutics Corporation Information
Table 106. Envisia Therapeutics Description and Business Overview
Table 107. Envisia Therapeutics Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 108. Envisia Therapeutics Sustained Release Ocular Drug Delivery Systems Product
Table 109. Envisia Therapeutics Recent Developments/Updates
Table 110. GrayBug Corporation Information
Table 111. GrayBug Description and Business Overview
Table 112. GrayBug Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 113. GrayBug Sustained Release Ocular Drug Delivery Systems Product
Table 114. GrayBug Recent Developments/Updates
Table 115. Innocore Pharmaceuticals Corporation Information
Table 116. Innocore Pharmaceuticals Description and Business Overview
Table 117. Innocore Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 118. Innocore Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Product
Table 119. Innocore Pharmaceuticals Recent Developments/Updates
Table 120. OHR Pharmaceuticals Corporation Information
Table 121. OHR Pharmaceuticals Description and Business Overview
Table 122. OHR Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 123. OHR Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Product
Table 124. OHR Pharmaceuticals Recent Developments/Updates
Table 125. PolyActiva Corporation Information
Table 126. PolyActiva Description and Business Overview
Table 127. PolyActiva Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 128. PolyActiva Sustained Release Ocular Drug Delivery Systems Product
Table 129. PolyActiva Recent Developments/Updates
Table 130. TheraKine Corporation Information
Table 131. TheraKine Description and Business Overview
Table 132. TheraKine Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 133. TheraKine Sustained Release Ocular Drug Delivery Systems Product
Table 134. TheraKine Recent Developments/Updates
Table 135. Key Raw Materials Lists
Table 136. Raw Materials Key Suppliers Lists
Table 137. Sustained Release Ocular Drug Delivery Systems Distributors List
Table 138. Sustained Release Ocular Drug Delivery Systems Customers List
Table 139. Sustained Release Ocular Drug Delivery Systems Market Trends
Table 140. Sustained Release Ocular Drug Delivery Systems Market Drivers
Table 141. Sustained Release Ocular Drug Delivery Systems Market Challenges
Table 142. Sustained Release Ocular Drug Delivery Systems Market Restraints
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Sustained Release Ocular Drug Delivery Systems
Figure 2. Global Sustained Release Ocular Drug Delivery Systems Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Sustained Release Ocular Drug Delivery Systems Market Share by Type in 2022 & 2034
Figure 4. Liposome Product Picture
Figure 5. Microcapsules/Nanocapsules Product Picture
Figure 6. Microspheres/Nanosptheres Product Picture
Figure 7. Implants Product Picture
Figure 8. Global Sustained Release Ocular Drug Delivery Systems Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 9. Global Sustained Release Ocular Drug Delivery Systems Market Share by Application in 2022 & 2034
Figure 10. Cataract
Figure 11. Glaucoma
Figure 12. Corneal Transplantation
Figure 13. Others
Figure 14. Global Sustained Release Ocular Drug Delivery Systems Revenue, (US$ Million), 2018 VS 2022 VS 2034
Figure 15. Global Sustained Release Ocular Drug Delivery Systems Market Size (2018-2034) & (US$ Million)
Figure 16. Global Sustained Release Ocular Drug Delivery Systems Sales (2018-2034) & (K Pcs)
Figure 17. Global Sustained Release Ocular Drug Delivery Systems Average Price (USD/Pcs) & (2018-2034)
Figure 18. Sustained Release Ocular Drug Delivery Systems Report Years Considered
Figure 19. Sustained Release Ocular Drug Delivery Systems Sales Share by Manufacturers in 2022
Figure 20. Global Sustained Release Ocular Drug Delivery Systems Revenue Share by Manufacturers in 2022
Figure 21. The Global 5 and 10 Largest Sustained Release Ocular Drug Delivery Systems Players: Market Share by Revenue in 2022
Figure 22. Sustained Release Ocular Drug Delivery Systems Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 23. Global Sustained Release Ocular Drug Delivery Systems Market Size by Region (US$ Million): 2018 VS 2022 VS 2034
Figure 24. North America Sustained Release Ocular Drug Delivery Systems Sales Market Share by Country (2018-2034)
Figure 25. North America Sustained Release Ocular Drug Delivery Systems Revenue Market Share by Country (2018-2034)
Figure 26. U.S. Sustained Release Ocular Drug Delivery Systems Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 27. Canada Sustained Release Ocular Drug Delivery Systems Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 28. Europe Sustained Release Ocular Drug Delivery Systems Sales Market Share by Country (2018-2034)
Figure 29. Europe Sustained Release Ocular Drug Delivery Systems Revenue Market Share by Country (2018-2034)
Figure 30. Germany Sustained Release Ocular Drug Delivery Systems Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 31. France Sustained Release Ocular Drug Delivery Systems Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 32. U.K. Sustained Release Ocular Drug Delivery Systems Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 33. Italy Sustained Release Ocular Drug Delivery Systems Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 34. Russia Sustained Release Ocular Drug Delivery Systems Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 35. Asia Pacific Sustained Release Ocular Drug Delivery Systems Sales Market Share by Region (2018-2034)
Figure 36. Asia Pacific Sustained Release Ocular Drug Delivery Systems Revenue Market Share by Region (2018-2034)
Figure 37. China Sustained Release Ocular Drug Delivery Systems Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 38. Japan Sustained Release Ocular Drug Delivery Systems Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 39. South Korea Sustained Release Ocular Drug Delivery Systems Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 40. India Sustained Release Ocular Drug Delivery Systems Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 41. Australia Sustained Release Ocular Drug Delivery Systems Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 42. Taiwan Sustained Release Ocular Drug Delivery Systems Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 43. Indonesia Sustained Release Ocular Drug Delivery Systems Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 44. Thailand Sustained Release Ocular Drug Delivery Systems Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 45. Malaysia Sustained Release Ocular Drug Delivery Systems Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 46. Philippines Sustained Release Ocular Drug Delivery Systems Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 47. Latin America Sustained Release Ocular Drug Delivery Systems Sales Market Share by Country (2018-2034)
Figure 48. Latin America Sustained Release Ocular Drug Delivery Systems Revenue Market Share by Country (2018-2034)
Figure 49. Mexico Sustained Release Ocular Drug Delivery Systems Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 50. Brazil Sustained Release Ocular Drug Delivery Systems Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 51. Argentina Sustained Release Ocular Drug Delivery Systems Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 52. Middle East & Africa Sustained Release Ocular Drug Delivery Systems Sales Market Share by Country (2018-2034)
Figure 53. Middle East & Africa Sustained Release Ocular Drug Delivery Systems Revenue Market Share by Country (2018-2034)
Figure 54. Turkey Sustained Release Ocular Drug Delivery Systems Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 55. Saudi Arabia Sustained Release Ocular Drug Delivery Systems Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 56. U.A.E Sustained Release Ocular Drug Delivery Systems Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 57. Global Sales Market Share of Sustained Release Ocular Drug Delivery Systems by Type (2018-2034)
Figure 58. Global Revenue Market Share of Sustained Release Ocular Drug Delivery Systems by Type (2018-2034)
Figure 59. Global Sustained Release Ocular Drug Delivery Systems Price (USD/Pcs) by Type (2018-2034)
Figure 60. Global Sales Market Share of Sustained Release Ocular Drug Delivery Systems by Application (2018-2034)
Figure 61. Global Revenue Market Share of Sustained Release Ocular Drug Delivery Systems by Application (2018-2034)
Figure 62. Global Sustained Release Ocular Drug Delivery Systems Price (USD/Pcs) by Application (2018-2034)
Figure 63. Sustained Release Ocular Drug Delivery Systems Value Chain
Figure 64. Sustained Release Ocular Drug Delivery Systems Production Process
Figure 65. Channels of Distribution (Direct Vs Distribution)
Figure 66. Distributors Profiles
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed